Securities code:603520
R&D and innovation
R&D Overview
With several high-level R&D platforms, such as [Advanced Quality Research Platform, Crystallisation Platform, Microchannel Reaction Platform],our annual R&D investment could account for more than [6]% of the sales revenue.
R&D Cooperation
Starry cooperates with Zhejiang University, Xiamen University, East China University of Science and Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Nanchang University, Yichun University, Taizhou Universityand other institutions.
R&D Results
We have more than [90] patent applications, undertaked a number of national and provincial research projects, and successfully passed the achievement examinations.
Copyright © Zhejiang Starry Pharmaceutical Co., Ltd. All Rights Reserved.
Powered by www.300.cn
![图片名称 图片名称](/npublic/img/s.png)
![图片名称 图片名称](/npublic/img/s.png)
Wap
CONTACT US
Tel: 0576-87718628 / 021-37916067
E-mail: sales@starrypharma.com
Zhejiang Starry Pharmaceutical Co., Ltd.
Add: No.l Starry Road of Xianju, Modern IndustriaL, Centralization Zone, Xianju, Zhejiang, China
Shanghai Starry Pharmaceutical Co., Ltd.
Add: No.500 Maoye Road,Jinshan District 201506, Shanghai city, China
Zhejiang Taizhou Hisyn Pharmaceutical Co., Ltd.
Add: Chemical and Medical Raw Materials Base, Linhai Park, Zhejiang, China
Jiangxi Starry Pharmaceutical Co., Ltd.
Add: North of the Wuyl Road,Salt chemical Base, Zhangshu, Jiangxi, 331200, P.R.China
Imax Diagnostic Imaging Limited
Add: Phoenix House, Room 137 Monahan Road, CorkT12H1XY Republic of lreland
E-mail:info@imaxdiagnostic.com
Tel: 00353 21 451 9990
REQUEST A QUOTE